Status:
WITHDRAWN
Patient-controlled Versus Anesthesiologist-controlled Propofol-remifentanil in Awake Craniotomy
Lead Sponsor:
University Health Network, Toronto
Conditions:
Awake Craniotomy for Brain Tumour Surgery
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Awake craniotomy for removal of brain tumour is performed because the tumour may be located close to areas of the brain that control specific functions such as movement or speech. Local anaesthesia (f...
Eligibility Criteria
Inclusion
- Adult patients more than 18 years of age
- ASA I, II or III
- Scheduled to undergo awake craniotomy for elective supratentorial tumor resection.
Exclusion
- patients with allergy to the drugs being used.
- patients at risk for pulmonary aspiration eg patients with history of GERD, gastroparesis (eg diabetic) and obesity.
- patients with BMI 35 or above
- patients with severe cardiovascular or respiratory diseases (ASA IV or higher).
- patients who are pregnant.
- patients with alcohol or substance abuse.
- patients who could not understand the concept of PCSA.
- patients who do not understand and are unable to follow instructions for the study due to a language barrier
- lack of informed consent.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00992940
Last Update
January 9 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto Western Hospital, University Health Network
Toronto, Ontario, Canada, M5T 2S8